What is the primary purpose of this Form 8-K filing?

This Form 8-K filing announces the execution of a material definitive agreement, specifically the Agreement and Plan of Merger between WellPoint, Inc. (now Elevance Health) and WellChoice, Inc. It provides details on the terms of the proposed merger and related agreements.

What consideration will WellChoice shareholders receive in the merger?

WellChoice shareholders will receive $38.25 in cash and 0.5191 shares of WellPoint stock for each share of WellChoice stock they own.

What role does The New York Public Asset Fund play in this transaction?

The New York Public Asset Fund, which owns approximately 62% of WellChoice's outstanding shares, has entered into a Voting Agreement with WellPoint. Under this agreement, the Fund is obligated to vote its shares in favor of the merger, which is crucial for securing shareholder approval.

What are the key conditions for the completion of the merger?

The consummation of the merger is subject to several conditions, including the approval of WellChoice's stockholders, receipt of necessary regulatory approvals (including from the Blue Cross Blue Shield Association), and the absence of any legal impediments. Both parties' representations and warranties must also be true and correct, and there must be no material adverse effect on WellChoice.

ELV 8-K: Material Agreements

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) filed a Form 8-K on September 30, 2005, to report the execution of a material definitive agreement: an Agreement and Plan of Merger with WellChoice, Inc. This filing outlines the key terms of the proposed merger, where WellChoice would merge with WellPoint's subsidiary, Merger Sub. The transaction is structured to provide WellChoice shareholders with a combination of cash and WellPoint stock, specifically $38.25 in cash and 0.5191 shares of WellPoint stock per WellChoice share. The agreement includes provisions for the treatment of stock options and equity awards for both companies. Furthermore, the report details a Voting Agreement between WellPoint and The New York Public Asset Fund, which owns approximately 62% of WellChoice's outstanding shares. This agreement obligates the Fund to vote its shares in favor of the merger, significantly increasing the likelihood of shareholder approval. Additionally, a Memorandum of Understanding is disclosed regarding the future employment of WellChoice's CEO, Michael A. Stocker, by WellPoint post-merger, including specific compensation and benefit arrangements.

Key Highlights

1WellPoint, Inc. (now Elevance Health) entered into a merger agreement with WellChoice, Inc. on September 27, 2005.
2WellChoice shareholders will receive $38.25 in cash and 0.5191 shares of WellPoint stock per share.
3The merger is subject to customary closing conditions, including shareholder approval, regulatory approvals, and the approval of the Blue Cross Blue Shield Association.
4A Voting Agreement was executed with The New York Public Asset Fund (owner of ~62% of WellChoice) to ensure their shares are voted in favor of the merger.
5WellChoice's CEO, Michael A. Stocker, has a Memorandum of Understanding for an employment agreement with WellPoint post-merger, detailing his role, salary, bonuses, and a significant lump-sum payment.
6The merger agreement allows for a potential termination fee of $230,000,000 payable by WellChoice under specific circumstances.
7The filing includes a notice to investors urging them to read the upcoming proxy statement/prospectus for important details about the transaction.

Elevance Health, Inc. 8-K Report, Material Agreement (Sep 30, 2005)

Summary

Key Highlights

Frequently Asked Questions